Heroin

The subjective experience of heroin is notoriously difficult to convey to someone who hasn't felt it — the experience is so far outside the normal range of human pleasure that it redefines the user's understanding of what "feeling good" can mean.

The Rush

With intravenous injection, the onset arrives within 7 to 15 seconds. Users describe a sudden wave of warmth erupting from the chest and radiating through the entire body, as though every cell has been wrapped in heated velvet. Reddit users have described it as "a warm blanket that covers your whole body — your mind, your spirit, your body, all covered up with this feeling of 'everything is right, no harm can be done.'" The rush lasts roughly two to five minutes and is widely described as the single most pleasurable sensation a human being can experience through chemistry. Smoking produces effects within 10-15 seconds with a slightly less intense rush. Insufflation takes 2-5 minutes for onset and produces a gentler wave.

The Plateau

The rush transitions into a sustained state of profound tranquility lasting three to five hours. This is not the buzzing euphoria of stimulants or the sensory expansion of psychedelics — it is a deep, all-encompassing stillness. Anxiety evaporates. Emotional pain becomes a distant abstraction. The internal monologue quiets to near-silence.

Users frequently describe this state as feeling "normal" for the first time — particularly those carrying chronic anxiety, trauma, or emotional pain. Many people who develop heroin dependence report that their first experience felt less like getting high and more like a revelation of what life was supposed to feel like. That perception becomes the psychological hook driving continued use.

The body enters near-total relaxation. Breathing slows. Pupils constrict to pinpoints. Itching around the nose and face is common due to histamine release. Nausea may occur in opioid-naive users. At higher doses, "nodding" develops — a drowsy oscillation between wakefulness and dreamlike half-sleep where consciousness fades in and out. Hunger, thirst, and sexual drive are suppressed.

The Comedown and the Trap

The effects ebb gradually, leaving a flat, foggy mental state. The contrast between the profound relief of intoxication and the return of baseline consciousness becomes, with repeated use, the central architecture of addiction. Tolerance develops with alarming speed — the mythologized first high becomes a benchmark users chase but never recapture. What began as a $10 escape can escalate to $100-a-day within weeks. Community members describe the shift from "using to get high" to "using to feel normal" to "using to not be sick" as the defining trajectory of heroin dependence.

Heroin vs. Fentanyl

Online communities draw sharp distinctions between actual heroin and fentanyl-contaminated products. Heroin is described as producing a longer-lasting, warmer, more emotionally rich experience, while fentanyl produces a rapid but "flat" rush with a much shorter duration, often driving compulsive redosing every 30-60 minutes.

Heroin is, at its core, a delivery vehicle for morphine. Its pharmacological story is one of clever chemistry enabling faster brain penetration, followed by the same opioid receptor interactions that morphine produces — but with a speed and intensity that changes the subjective experience entirely.

Absorption and Metabolism

When injected intravenously, heroin bypasses first-pass hepatic metabolism entirely. Its two acetyl groups (at positions 3 and 6 of the morphine skeleton) dramatically increase lipophilicity, allowing it to cross the blood-brain barrier within 15-20 seconds. This is the pharmacokinetic basis for the "rush" — a bolus of opioid activity hitting the brain all at once rather than trickling in gradually.

Once inside the CNS, esterase enzymes rapidly strip the acetyl groups. The first metabolite, 6-monoacetylmorphine (6-MAM), is itself a potent mu-opioid agonist and the unique metabolic marker that confirms heroin use specifically. 6-MAM is then further deacetylated to morphine, the primary active metabolite responsible for sustained opioid effects.

Oral administration subjects heroin to extensive first-pass metabolism, converting it almost entirely to morphine before it reaches the brain. This eliminates the rush and makes oral heroin pharmacologically equivalent to oral morphine.

Receptor Pharmacology

Morphine and 6-MAM act primarily as full agonists at mu-opioid receptors (MOR), G-protein coupled receptors distributed throughout the brain, spinal cord, and gut. MOR activation triggers the Gi/Go cascade: adenylyl cyclase is inhibited, cAMP levels drop, potassium channels open (hyperpolarizing the neuron), and voltage-gated calcium channels close. The net result is suppressed neuronal excitability and reduced neurotransmitter release.

In the ventral tegmental area, opioids produce euphoria through an indirect mechanism: they inhibit GABAergic interneurons that normally suppress dopaminergic neurons. Releasing these dopamine neurons from inhibition causes a surge of dopamine in the nucleus accumbens — the reward signal the brain interprets as intensely pleasurable. This disinhibition mechanism distinguishes opioids from stimulants, which increase dopamine through entirely different pathways.

Morphine also activates delta- and kappa-opioid receptors, contributing to additional analgesic effects and some dysphoric or sedative components. Heroin triggers greater histamine release than synthetic opioids like hydromorphone, producing the characteristic flushing and itching.

Neuroadaptation and Dependence

Chronic MOR activation triggers neuroadaptive changes: the cAMP pathway upregulates (adenylyl cyclase superactivation), receptors desensitize and internalize, and endogenous opioid production downregulates. These changes constitute physical dependence. When heroin is withdrawn, the hyperexcitable state previously masked by continuous agonism is suddenly unmasked, producing the sympathetic storm of withdrawal: tachycardia, sweating, diarrhea, piloerection, insomnia, and intense dysphoria.

The story of heroin is one of medicine's great cautionary tales — a drug designed to be a safer morphine that became synonymous with addiction and overdose death.

The opium poppy (Papaver somniferum) has been cultivated since at least 3400 BC in Mesopotamia, where the Sumerians called it Hul Gil — the "joy plant." The isolation of morphine from opium by Friedrich Serturner around 1804 represented the birth of modern pharmacology. Morphine was revolutionary, but its addictive potential became devastatingly clear during the American Civil War, where widespread medical use created a generation of dependent veterans — "soldier's disease."

Diacetylmorphine was first synthesized in 1874 by C.R. Alder Wright at St. Mary's Hospital Medical School in London. The compound attracted little attention until 1897, when Felix Hoffmann at Bayer independently re-synthesized it — eleven days after synthesizing aspirin. Bayer coined the trade name "Heroin" (from the German heroisch, "heroic") and marketed it in 1898 as a non-addictive cough suppressant. The irony was staggering: a drug developed to cure morphine addiction proved even more addictive.

By 1910, heroin's addictive potential was recognized. The US Harrison Narcotics Tax Act of 1914 regulated its sale; by 1924 Congress banned non-medical use. The League of Nations banned it internationally in 1925. Bayer lost its "Heroin" and "Aspirin" trademarks under the 1919 Treaty of Versailles.

Through the mid-20th century, heroin became embedded in jazz and counterculture — from Billie Holiday to Kurt Cobain. The 1970s "heroin epidemic" prompted Nixon-era drug enforcement. The 21st century brought the worst chapter: over-prescription of pharmaceutical opioids created millions of dependent patients who turned to heroin when cut off, then fentanyl infiltrated the supply beginning around 2013, causing overdose deaths to skyrocket past 100,000 annually by 2023. Expanded harm reduction and naloxone access contributed to a roughly 27% decline by 2024.